Breaking News, Collaborations & Alliances

OM Pharma and AstraZeneca Sign Collaboration Agreement

Will improve the accessibility of Broncho-Vaxom and accelerate its growth in the Chinese market.

By: Contract Pharma

Contract Pharma Staff

OM Pharma and AstraZeneca finalized a strategic collaboration agreement today at a partnership signing ceremony in Shanghai.   The strategic collaboration agreement grants AstraZeneca the exclusive right to import, distribute and promote OM Pharma’s Broncho-Vaxom (Bacterial Lysates – OM-85) in China (excluding Hong Kong, Macau, and Taiwan).   Broncho-Vaxom is a therapeutic agent that effectively prevents and treats recurrent or acute respiratory infections in adult and pediatric patients b...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters